Citizenship For Sale: Trump’s $5M ‘Gold Card’ Visa Seems Designed To Install A Rich Foreign Overclass
Let's Make America Victorian England Again!
5 Notable Health Tech Funding Announcements In February
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds.
The Hidden Threat: How Fake Identities used by Remote Employees Put Your Business at Risk—and How to Defend Against This
Reach out to continue the conversation on how to most effectively detect, prevent, and correct this or other types of fraud, cybercrime, misconduct, and non-compliance.
KPMG Becomes The First Member Of The Big Four To Open US Law Firm
Wave goodbye to Biglaw, and say hello to Big Four Law!
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees To Acquisition By Private Equity
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.
What Sets 2025’s Digital Health Funding Environment Apart From Previous Years?
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years.
Whatever Your Politics, Join ‘No-Buy Friday’ On February 28 As A Great Economic Experiment
It's an impossibly complex web of moral turpitude out there in corporate America.
How Lexis’ CounselLink+ Reimagines The Redline
Contracts are now integrated into an end-to-end system, and efficiencies abound.
We Shouldn’t Just Compete With China’s Artificial Intelligence, We Should Promote The Development Of Actual Intelligence
Consider how much better we'd be doing than China on AI, and everything else, if our population as a whole could dramatically out-think China's.
Stella McCartney Re-Acquires Minority Stake In Brand From LVMH
The designer will remain as Global Ambassador on Sustainability at the French fashion company.
Never Take A Case Billed Out On An Hourly Basis Without A Retainer Big Enough To Easily Cover A Month’s Fees
This is easier to implement than you might think.
Prisoner’s Dilemma: Why Running A Law Firm Requires A Unique Mindset
If you’re looking for a completely unique viewpoint on law firm management, well, you’ve found it.
The Next Chapter In Legal Tech Innovation: Introducing Protégé™
Meet LexisNexis Protégé™, the new AI assistant that leverages personalization choices controlled by the user or their organization to optimize the individual’s AI experience.
The World Feels Pretty Weird, Which Is Not A Good Reason To Change Up Your Retirement Investments
The vast majority who try to time the market fail.
VC Firm Foresite Capital Dishes On Biotech Innovation In China, Opportunities In Immunology
China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is booming as well as therapeutic areas where he sees promising science.
Trump’s Former Ethics Watchdog Sounds The Alarm On What’s Yet To Come For This Administration
The first thing Americans are getting fleeced on is the $TRUMP memecoin.
Healthcare AI Company Rakes In $275M, Kicking Off What Will Likely Be Another Hot Year For AI Funding
Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 million. The company has plans to go public 'at some point,' but it isn’t in any hurry, said CEO Abhinav Shashank.
Why Walgreens Is Reportedly Considering A Private Equity Buyer
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.